Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Kailera Therapeutics Launches with $400 Million Series A
Kailera Therapeutics Appoints Jamie Coleman as Chief Commercial Officer ...
Kailera Therapeutics - 22 Fillmore
Kailera Therapeutics Launches with $400 Mn Series A Funding
Kailera raises $600M in Series B, advances KAI-9531 into Phase III ...
Kailera | GLP-1 Therapies for Obesity Management | Contact
#kainections #kaicrew #kaileratx | Kailera Therapeutics
Kailera | GLP-1 Therapies for Obesity Care | Open Positions
Kailera Therapeutics Announces $600 Million Series B | citybiz
Kailera | GLP-1 Therapy for Obesity | Ribupatide
Kailera | GLP-1 Therapies for Obesity Care | About Us
Kailera Therapeutics: Next-Gen GLP-1 Obesity Therapies | ChatGate
Kailera Therapeutics | GLP-1 Therapies for Obesity Care
Kailera nets $600m to power Phase III launch of obesity drug ...
Kailera Therapeutics | GLP-1 Therapies for Clinical Obesity
#kaicrew #kainections #kaileratx #obesity #oac #weightbias | Kailera ...
Kailera Therapeutics, an obesity drug startup, raises $600 million
Kailera Therapeutics Stock | Valuation, Funding, Investors | Notice.co
Kailera | GLP-1 Therapies for Weight Control | Leadership
Kailera | GLP-1 Therapies for Obesity Care | Life at Kailera
Kailera Therapeutics Launches with Ambitious Plans for GLP-1 Drugs ...
Kailera Therapeutics Launches with $400 Million Series A Financing to ...
Investors raise $400 million for obesity startup Kailera Therapeutics
Kailera launches with $400M series A, 4 Chinese obesity drugs
Kailera Launches With $400M to Advance China-Developed Obesity Assets ...
BioCentury - Kailera seeks to differentiate GLP-1/GIP agonist after ...
Kailera emerges with $400m to advance next-generation weight loss drugs
Kailera Therapeutics $600M Series B for KAI-9531 Obesity Drug
#kailife #kaicrew #kailife #kaileratx | Kailera Therapeutics
Kailera Therapeutics Raises $600 Million Series B to Advance Obesity ...
Kailera Therapeutics emerges from stealth with $400M for obesity drugs ...
Kailera jumps on weight-loss drug bandwagon with $400 mln early-stage ...
Jiangsu and Kailera report positive topline data for 8mg HRS9531 GLP-1/GIP
Kailera nets $600M more to advance Zepbound-like obesity drug ...
Kailera Therapeutics Announces $600 Million Series B Financing to ...
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Kailera Therapeutics - Intersect Management
#hiring #biotechjobs #biotechnology #careers | Kailera Therapeutics
Kailera Launches With $400M Series A And Clutch Of Chinese Obesity ...
Kailera Therapeutics Launches Global Phase 3 Program for Ribupatide in ...
$600m round will help Kailera push obesity drug into phase 3 | pharmaphorum
Kailera | GLP-1 Therapies for Obesity Care | Clnical Trials
New obesity company Kailera launches with $400 million financing ...
Novo Nordisk News | The Pharmaletter
kaillera(카일레라) 서버 실행하기 : 네이버 블로그
#kaileaders #kaileaders #meetthemanager #kaicrew #kaileratx # ...
6亿美元！恒瑞Newco再获融资医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
恒瑞医药GLP-1类新药“出海”：Kailera成立、B轮6亿融资与全球3期试验将启_摩熵医药
Kailera: Betting on China's R&D for the next weight-loss miracle drug
4亿美元A轮融资！潜在“best-in-class”减肥疗法即将进入3期临床_腾讯新闻
